Grant: Knowledge Synthesis Grant
McMaster University
$100,000.00
Efficacy and Safety of Preventions for Preterm Birth: A Systematic Review and Network Meta-Analysis
EF 2015-16
Résumé
(Strengthened thanks to Reviewers’ comments)
BACKGROUND: Preterm birth (PTB), a leading cause of infant mortality and childhood morbidity, affects 1 in 13 births (8%) in Canada and globally 15 million infants yearly. PTB impacts the infant, family, healthcare and economy.
Currently, 3 options for primary prevention of preterm birth have shown benefit compared to placebo or usual care in individual meta-analyses: 1) progesterone (a hormone), 2) cerclage (a surgery to stitch shut the uterus) and 3) pessary (a device placed in the vagina to support the uterus).
However, concerns exist with each. Moreover, it is unknown which intervention is best for PTB prevention, limiting their use. Hence, a network meta-analysis is urgently needed, an ideal method to compare multiple health care treatments.
AIM:To identify the most efficacious and safe primary prevention strategy for PTB.
PRIMARY OBJECTIVES:
To determine the relative treatment effects of the interventions for primary prevention of preterm birth (progesterone, cerclage and pessary) using network meta-analysis.
To rank the prevention methods for preterm birth, generating a clinically meaningful hierarchy.
SECONDARY OBJECTIVES
To assess the efficacy and safety of each intervention in a complete synthesis of all relevant maternal and infant secondary outcomes (i.e. complications of interventions or sequelae of PTB).
METHODOLOGY: We will comprehensively search 6 electronic databases (MEDLINE, EMBASE, CINAHL, Cochrane CENTRAL, ISI Web of Science and Pubmed,) with a research librarian and hand search reference lists and trial registries. We will follow the Cochrane handbook, including published randomized control trials (RCT) in which asymptomatic women are randomly allocated to receive one or combinations of the following interventions for prevention of preterm birth: progesterone, cerclage, pessary, and are compared to placebo, usual care or each other. Our primary outcomes will be: PTB <34 and <37 weeks, and secondary will include <24 and 28 weeks, mortality and morbidity in women and infants. Analyses will be done separately in singleton and multiples given worse outcomes in multiples. Subgroup analyses will stratify by indication for prevention (short cervix, previous PTB, etc), cervix length, mode of delivery of progesterone, etc. We will collect information on other interventions which mitigate PTB’s effects. We will appraise the data using Cochrane Risk of Bias and Grades of Recommendation, Assessment, Development and Evaluation (GRADE) assessment tool. We will test for heterogeneity using Cochran’s Q statistic and quantify it with the I-squared statistic. Using the random effects model, we will calculate summary effects using the frequentist and Bayesian approaches in STATA and WinBugs, respectively, and will estimate ranking probabilities.
Our Knowledge Users (KU) have given input into this grant (integrated knowledge translation, KT). We will hold an end-of-grant workshop to tailor key messages and publish them as the basis for new national guidelines.
EXPERTISE: Our multinational team, experienced in knowledge synthesis, involves: patients, KU, obstetricians, family physicians, midwives, pediatricians, clinical epidemiologists, guideline authors, inter/national organizations, a Cochrane methods statistician, and librarian.
IMPORTANCE: Using cutting-edge network met-analysis, we will provide and transmit evidence to women and clinicians on the best PTB prevention.
Programme
Knowledge Synthesis Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
330890
Name
McDonald Sarah D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Clinical
Prcname2
Knowledge Synthesis Grant
Projecttitle
Efficacy and Safety of Preventions for Preterm Birth: A Systematic Review and Network Meta-Analysis
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Knowledge Synthesis Grant
Keyworddelim
Cerclage; Efficacy; Neonatal Morbidity; Neonatal Mortality; Network Meta-Analysis; Pessary); Preterm Birth; Prevention Of Preterm Birth; Ranking Preventions (Progesterone; Safety
Competitiondate
201505
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mundle, William R; McDonald, Sarah D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~
Abstract
<html>
<body>
<p>
<i><b>(Strengthened thanks to Reviewers’ comments)</b></i>
<br>
<br>
<strong>BACKGROUND:</strong> <strong>Preterm birth (PTB), a leading cause of infant mortality</strong> and childhood morbidity, <strong>affects 1 in 13 births (8%) in Canada and globally 15 million infants yearly.</strong> PTB impacts the infant, family, healthcare and economy.<br>
<br>
<strong>Currently, 3 options for primary prevention of preterm birth</strong> have shown benefit compared to placebo or usual care in individual meta-analyses: <strong>1) progesterone</strong> (a <em>hormone</em>), <strong>2) cerclage</strong> (a <em>surgery</em> to stitch shut the uterus) and <strong>3) pessary</strong> (a <em>device</em> placed in the vagina to support the uterus).<br>
<br>However, concerns exist with each. Moreover, it is unknown which intervention is best for PTB prevention, limiting their use. <em>Hence, a <strong>network meta-analysis</strong> is urgently needed, an ideal method to compare multiple health care treatments</em>.<br>
<br>
<strong>AIM</strong>:To identify the most efficacious and safe primary prevention strategy for PTB.<br>
<br>
<strong>PRIMARY OBJECTIVES:</strong>
<br>To determine the <em>relative treatment effects</em> of the interventions for primary prevention of preterm birth (progesterone, cerclage and pessary) using network meta-analysis.<br>
<br>To <em>rank</em> the prevention methods for preterm birth, <em>generating a clinically meaningful hierarchy</em>.<br>
<br>
<strong>SECONDARY OBJECTIVES</strong>
<br>To <em>assess the efficacy and safety</em> of each intervention in a complete synthesis of all relevant maternal and infant <em>secondary</em> outcomes (i.e. complications of interventions or sequelae of PTB).<br>
<br>
<strong>METHODOLOGY:</strong> We will comprehensively search <u>6 electronic databases</u> (MEDLINE, EMBASE, CINAHL, Cochrane CENTRAL, ISI Web of Science and Pubmed,) with a research librarian and hand search reference lists and trial registries. We will follow the <u>Cochrane handbook</u>, including published randomized control trials (RCT) in which asymptomatic women are randomly allocated to receive one or combinations of the following interventions for prevention of preterm birth: progesterone, cerclage, pessary, and are compared to placebo, usual care or each other. Our <u>primary outcomes</u> will be: <em>PTB <34</em> and <em><37 weeks</em>, and secondary will include <24 and 28 weeks, mortality and morbidity in women and infants. Analyses will be done <u>separately in singleton and multiples</u> given worse outcomes in multiples. Subgroup analyses will stratify by indication for prevention (short cervix, previous PTB, etc), cervix length, mode of delivery of progesterone, etc. We will collect information on other interventions which mitigate PTB’s effects. We will appraise the data using <u>Cochrane Risk of Bias and</u> <u>Grades of Recommendation, Assessment, Development and Evaluation</u> <u>(GRADE)</u> assessment tool. We will test for heterogeneity using Cochran’s Q statistic and quantify it with the I-squared statistic. Using the <u>random effects model</u>, we will calculate summary effects using the frequentist and Bayesian approaches in <u>STATA and WinBugs</u>, respectively, and will estimate ranking probabilities.<br>
<br>Our Knowledge Users (KU) have given input into this grant (<strong><u>integrated</u></strong> <u>knowledge translation, KT</u>). We will hold an <em>end-of-grant</em> <u>workshop</u> to tailor key messages and publish them as the basis for new national guidelines.<br>
<br>
<strong>EXPERTISE</strong>: Our multinational team, experienced in knowledge synthesis, involves: patients, KU, obstetricians, family physicians, midwives, pediatricians, clinical epidemiologists, guideline authors, inter/national organizations, a Cochrane methods statistician, and librarian.<br>
<br>
<strong>IMPORTANCE:</strong> Using cutting-edge network met-analysis, we will provide and transmit evidence to women and clinicians on the best PTB prevention.<br>
</p>
</body>
</html>